FCB New York and FDA’s Center for Tobacco Products announced the launch of the next installment of “Little Lungs,” an effective smoking prevention campaign for teens that portrays a set of lungs stunted by teenage smoking.
Teens and tweens with cystic fibrosis are trying to teach other teens a thing or two about social distancing as part of The Social Distance Squad, a program developed by AREA 23, an FCB Health Network company, in partnership with five leading CF nonprofits.
Pfizer’s oral Janus kinase 1 (JAK1) inhibitor, abrocitinib, continues to post strong clinical trial results as a treatment for atopic dermatitis.
FCB New York and the U.S. FDA announced that they have launched the newest evolution of “The Real Cost” youth tobacco prevention campaign.
Sedentary teens may be more likely than their active peers to be depressed, and a new study suggests even light exercise like walking might help reduce this risk.
Health investigators are casting a wide net to understand what is sickening hundreds of vapers across the United States and still have not ruled out any product on the market.
Researchers say universities across the United States have been slow to adopt anti-tobacco policies on campuses despite public health efforts to curb tobacco use, especially among teens and young adults.
San Francisco is the first major city in the United States to ban the sale of e-cigarettes as officials look to control the rapid uptick in teenage use of nicotine devices made by companies such as Juul Labs Inc.
The U.S. Food and Drug Administration plans to meet with top-level executives of e-cigarette makers, the agency’s chief said, hinting that some companies seem to be backing away from commitments related to youth’s access to e-cigarettes.
The FDA announced sweeping new restrictions on flavored tobacco products, including electronic cigarettes popular among teenagers in an effort to prevent a new generation of nicotine addicts.